20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T11630 | IFN alpha-IFNAR-IN-1 hydrochloride | Others , IFNAR | |
IFN alpha-IFNAR-IN-1 hydrochloride is an inhibitor of the interaction between IFN-α and IFNAR. IFN alpha-IFNAR-IN-1 hydrochloride inhibits MVA-induced IFN-α responses by BM-pDCs with IC50 of 2-8 μM. | |||
T38158 | StA-IFN-1 | ||
StA-IFN-1 is an inhibitor of the interferon (IFN) induction pathway with an IC50 value of 4.1 μM in a GFP reporter assay for IFN induction similar to TPCA-1 , which specifically inhibits the IKKβ component of the IFN ind... | |||
T11630L | IFN alpha-IFNAR-IN-1 | Others | |
IFN alpha-IFNAR-IN-1 is a nonpeptidic, low-molecular-weight inhibitor of the interaction between IFN-α and IFNAR. It inhibits MVA-induced IFN-α responses by BM-pDCs (IC50: 2-8 μM). | |||
TP1117 | IFN-α Receptor Recognition Peptide 1 | IRRP1 | |
IFN-α Receptor Recognition Peptide 1, associated with receptor interactions, is a peptide of IFN-α. | |||
T76637 | IFN-γ Antagonist 1 | ||
IFN-γ Antagonist 1 (AYCRDGKIGPPKLDIRKEEKQI), an interferon γ (IFN γ) antagonist, effectively inhibits IFN-γ induced HLR/DR antigen expression in Colon 205 cells, demonstrating an IC50 of approximately 35 μM. This compoun... | |||
T83147 | Albinterferon alfa-2B | alb-IFN | |
Albinterferon alfa-2B (alb-IFN), a recombinant protein, comprises interferon alfa-2b conjugated to human albumin and is utilized in the study of chronic hepatitis C [1]. | |||
T78262 | Anti-Mouse IFN gamma Antibody (H22) | IFNAR | |
Anti-Mouse IFN Gamma Antibody is a host Armenian Hamster-derived anti-mouse IFN gamma immunoglobulin G (IgG) inhibitor. | |||
T76638 | IFN-γ Antagonist 1 acetate | ||
IFN-γ Antagonist 1 (AYCRDGKIGPPKLDIRKEEKQI) acetate, an interferon γ (IFN γ) antagonist, effectively inhibits the expression of HLR/DR antigen in Colon 205 cells induced by IFN-γ, with an inhibition concentration (IC 50)... | |||
T81259 | Rontalizumab | RhuMab IFNalpha,Anti-Human IFN alpha Recombinant Antibody | |
Rontalizumab, a humanized IgG1 monoclonal antibody, targets IFN-α and is utilized in research on systemic lupus erythematosus[1]. | |||
T9043 | AS1810722 | P450 , STAT | |
AS1810722, a fused bicyclic pyrimidine derivative, is an orally active and potent inhibitor of STAT6, demonstrating an IC50 of 1.9 nM. It exhibits effective inhibition of CYP3A4, positioning it as a promising candidate f... | |||
T12933 | SM-276001 | TLR , COX | |
SM-276001 is a potent selective agonist of TLR7,and is an orally active interferon (IFN) inducer. | |||
T21694 | (R)-Lisofylline | (R)-Lisophylline | STAT |
(R)-Lisofylline ((R)-Lisophylline) is an inhibitor of lysophosphatidic acid acyltransferase (IC50 = 0.6 µM). (R)-Lisofylline interrupts IL-12 signaling-mediated STAT4 activation and can be used in studies about the treat... | |||
T8692 | (Rac)-Benpyrine | TNF | |
(Rac)-Benpyrine is a potent and orally active inhibitor of TNF-α. | |||
T9616 | PD-1/PD-L1-IN-10 | PD-1/PD-L1 | |
PD-1/PD-L1-IN-10 is an orally active PD-1/PD-L1 inhibitor (IC50 of 2.7 nM) with potent anticancer efficacy. | |||
T1781 | GW9508 | GW 9508 | GPR , Potassium Channel |
GW9508(GW 9508) is a potent and selective agonist for FFA1 (GPR40), stimulates insulin secretion in a glucose-sensitive manner. | |||
T83628 | TNF/IFNγ-IN-1 | Antioxidant , TNF , COX | |
TNF/IFNγ-IN-1 (TGA) is a dual inhibitor of TNF and IFN-γ. TNF/IFNγ-IN-1 has potential antioxidant and anti-inflammatory activities for neurodegenerative diseases such as Alzheimer. | |||
T78263 | Anti-Mouse IFNAR1 Antibody (MAR1-5A3) | IFNAR | |
Anti-Mouse IFNAR1 Antibody (MAR1-5A3) is a neutralizing monoclonal antibody that specifically binds to IFNAR1, blocking its signaling both in vitro and in vivo. It is of the Mouse IgG1 kappa isotype and a corresponding i... | |||
T0867 | Bufexamac | Bufexamic acid | COX , HDAC |
Bufexamac (Bufexamic acid) is a COX inhibitor for IFN-α release with anti-inflammatory, analgesic, and antipyretic action. | |||
T19675 | SM360320 | CL-087,SM 360320,CL 087,1V136,SM-360320,CL087 | TLR |
SM360320 (CL-087) is an effective and selective agonist of TLR7. SM360320 inhibits HCV replication in hepatocytes via a type I IFN-independent mechanism in addition to its IFN-mediated activity. SM360320 can be used for ... | |||
T22142 | RO8191 | RO4948191,CDM-3008 | HCV Protease , HBV , JAK , IFNAR , STAT |
RO8191 (CDM-3008) (CDM-3008) is an agonist of interferon (IFN) receptor. |